neuroendocrine-tumor-treatment-market

Neuroendocrine Tumor Treatment Market By Drug Class (Everolimus, Sunitinib, Lu-Dotatate, Lanreotide And Octreotide) - Growth, Future Prospects & Competitive Analysis, 2019 – 2029

05 Mar 2021 Format PDF icon PPT icon XLS icon Request Sample
Choose Licence Type
$4325
$6325
$12650
Why Acute
View Other Reports